AstraZeneca (AZNCF) Stock Statistics & Valuation Metrics

AstraZeneca has a market cap or net worth of £217.10B. The enterprise value is $251.14B.

AstraZeneca has 1,550,670,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

AstraZeneca’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 10.30%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, AstraZeneca had revenue of 54.07B and earned 7.04B in profits. Earnings per share was 4.54.

In the last 12 months, operating cash flow was 13.09B and capital expenditures -3.41B, giving a free cash flow of 9.68B billion.

AstraZeneca pays an annual dividend of $2.128, resulting in a dividend yield of 2.19%

AstraZeneca upcoming earnings date is Jul 29, 2025, Before Open (Confirmed).

AstraZeneca as a current ratio of 0.93, with Debt / Equity ratio of 77.29%

In the past 12 months, AstraZeneca has paid 1.65B in taxes.

AstraZeneca EV to EBITDA ratio is 14.74, with an EV/FCF ratio of 31.29.

AstraZeneca has £5.39B in cash and marketable securities with $31.72B in debt, giving a net cash position of £26.32B billion.

Gross margin is 81.41%, with operating margin of 18.50%, and net profit margin of 13.01%.

The average price target for AstraZeneca is £181.46, which is 11.43% higher than the current price. The consensus rating is Moderate Buy